European Union Drugs Agency (EUDA) announcement
Drug‑related infectious diseases — including HIV, hepatitis B and hepatitis C — continue to pose major health challenges for people who inject drugs (PWID). Changing risk factors, limited access to harm‑reduction services and structural barriers to healthcare contribute to a disproportionate burden of infection, illness and mortality within this population.
The European Union Drugs Agency (EUDA) released an updated technical protocol providing practical guidance for planning and implementing surveys among PWID. It outlines available methodological approaches, their advantages and limitations, and includes examples of best practice from across Europe.
Together with the accompanying questionnaires and resources, it supports national and local teams in designing robust and context‑appropriate studies to assess the progress towards the elimination of viral hepatitis as a public health threat and ending the HIV/AIDS epidemic among this key population.
Access the toolkit here.
Source : EUDA
Related HIV and Co-Infections News
-
[CROI 2026] aidsmap: Younger, mobile men especially likely to not know they have HIV in eastern and southern Africa
-
HIV i-Base: GLP-1 receptor agonists reduce substance use disorder: a role for addiction to chemsex drugs?
-
Health Policy Watch: Global Fund faces $5bn shortfall as France slashes support, EU delays pledge
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.